Be confident enough to show your vulnerability, w/former Merck CEO Ken Frazier
Rapid Response
00:00
Investing in Scientific Research
Investing is part of the mandate at general catalist. You want to be patient, but impatient, right? Like you don't want to waste resources. But we've seen some technologies that struggled for years to get traction and then suddenly became critical. In the case of m r anda, m ra had been used in other disease contexts unsuccessfully, but for a single stranddna like covet 19,. it turns out to be perfect for that. The same with imuna oncology. For years, people ere very sceptical about it. So people often say, in the tech field, you want to fail fast. And so you want to continue function, or to
Transcript
Play full episode
